Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

33c39a7b-e8d2-4240-aa13-d44a77eec198 - samples

ABSTRACT: This dataset contains subtype assignments for 271 tumor samples profiled by RNA-seq.

PROVIDER: EGAD00001006926 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

138ff350-f3cd-4e2f-8310-4592f0a3fed2 - samples

Project description:This dataset contains log2(TPM + 1) for 271 tumor samples profiled by RNA-seq for the subset of genes used for validation of the NMF cluster assignments.

| EGAD00001006928 | EGA

8c328360-cab0-4718-b319-3978511dcca1 - samples

Project description:This dataset contains log2(TPM + 1) for 271 tumor samples profiled by RNA-seq for the entire transcriptome.

| EGAD00001006927 | EGA

4abd8d2a-485c-4457-a98a-15239ce7cc97 - samples

Project description:This dataset contains counts for 699 tumor samples profiled by RNA-seq for the entire transcriptome for samples originating from OAK (GO28915).

| EGAD00001008628 | EGA

7ff013c8-cc1d-4992-bfe9-78c87a50dc0a - samples

Project description:This dataset contains counts for 192 tumor samples profiled by RNA-seq for the entire transcriptome for samples originating from POPLAR (GO28753).

| EGAD00001008630 | EGA

7c88a35c-7d54-401a-88d1-61e493ed227a - samples

Project description:This dataset contains log2(TPM + 1) for 192 tumor samples profiled by RNA-seq for the entire transcriptome for samples originating from POPLAR (GO28753).

| EGAD00001008390 | EGA

31951866-ad43-4c66-a529-f4a7d7c6e7e1 - samples

Project description:This dataset contains counts per million for 699 tumor samples profiled by RNA-seq for the entire transcriptome for samples originating from OAK (GO28915).

| EGAD00001008629 | EGA

90f7cb75-530e-4e59-9d82-71cc397da210 - samples

Project description:This dataset contains log2(TPM + 1) for 699 tumor samples profiled by RNA-seq for the entire transcriptome for samples originating from OAK (GO28915).

| EGAD00001008391 | EGA

5918d7ec-a027-4ae8-bb99-2285b7ca4b7c - samples

Project description:This dataset contains counts per million for 192 tumor samples profiled by RNA-seq for the entire transcriptome for samples originating from POPLAR (GO28753).

| EGAD00001008631 | EGA

Comprehensive miRNA expression profiling in human T-cell acute lymphoblastic leukemia by small RNA-sequencing

Project description:We profiled the full miRNA expression profile of 48 T-ALL patient samples from different subtypes by means of small RNA-sequencing, identifying for the first time subtype specific miRNA signatures. In addition we also profiled T-ALL cell lines by small RNA-sequencing, recapitulating the subtype specific miRNAs. Furthermore, profiling of CD34+ and CD4+CD8+ healthy donor thymocytes identified several novel potential oncogenic miRNAs or miRNAs with a tumor suppressive role in T-ALL. With these datasets, we complement the mRNA and lncRNA T-ALL subtype specific expression signatures with miRNAs, leading to the full transcriptomic profile of T-ALL subtypes.

2017-08-10 | GSE89978 | GEO

Stratification of Leiomyosarcoma molecular subtypes by 3' end RNA-sequencing: Toward precision medicine

Project description:Leiomyosarcoma (LMS) is a malignant neoplasm with smooth muscle differentiation. Little is known about its molecular heterogeneity and no targeted therapy currently exists for LMS. We demonstrate the existence of 3 molecular subtypes in a cohort of 99 cases and an independent cohort of 82 LMS. Two new FFPE tissue-compatible diagnostic immunohistochemical markers are identified: LMOD1 for subtype I LMS and ARL4C for subtype II LMS. Subtype I and subtype II LMS are associated with good and poor prognosis, respectively. The LMS subtypes show significant differences in expression levels for genes for which novel targeted therapies are being developed. Gene expression profiling was performed by 3' End RNA Sequencing (3SEQ), a next generation sequencing approach that does not rely on frozen tissue but can be performed on archival FFPE tissue. Samples included 99 LMS, 6 Undifferentiated Pleomorphic Sarcomas (UPS), 3 leiomyomas, 4 normal myometrium samples, and 1 case of Lymphangioleiomyomatosis (LAM). This study only includes the 99 LMS Samples. After gene expression levels were quantified by 3SEQ analysis pipeline, Consensus Clustering with bootstrap method was used to determine that the dataset contained three robust subtypes, and Silhouette analysis was performed to validate the subtype assignments. Two class SAM analysis (Significance Analysis of Microarrays) was performed to identify genes expressed differentially between each subtype of LMS with FDR of 0.05. Immunohistochemical staining was used to validate the potential diagnostic and prognostic markers from 3SEQ data on a tissue microarray.

2015-05-19 | E-GEOD-45510 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data